# ==========================================================
# SYNTHETIC CLINICAL TRIAL DATA GENERATOR
# Public Technical Specification - Block 1
# ==========================================================

# MODULE SCOPE

# This module documents the public interface and expected
# behavior of a synthetic clinical trial data generator.

# The initial development stage focuses on generating
# participant-level records for a fictional clinical trial.

# All records are synthetic and do not represent real
# patients or clinical observations.

# This file is documentation-only. Executable generation
# logic and internal simulation configurations are
# maintained separately.


# ----------------------------------------------------------
# 01. PARTICIPANT DATA GENERATION
# ----------------------------------------------------------

# 1.1 FUNCTION CONTRACT

# generate_patient_data(n_patients=150, seed=42)

# Input:
#   n_patients : int
#       Requested number of synthetic participants.

#   seed : int
#       Random seed controlling reproducibility.

# Output:
#   pandas.DataFrame
#       One record per synthetic participant.

# Expected behavior:
#   - Generate the requested participant population.
#   - Assign a unique identifier to each participant.
#   - Populate study and demographic attributes.
#   - Generate participant enrollment dates.
#   - Return a consistently structured DataFrame.

# -----------------------

# 1.2 OUTPUT SCHEMA

# patient_id
#   Participant identifier; unique and non-null.

# site
#   Fictional clinical investigation site.

# treatment_arm
#   Assigned fictional treatment group.

# status
#   Simulated participant participation status.

# age
#   Synthetic participant age.

# gender
#   Synthetic demographic classification.

# enrollment_date
#   Participant enrollment date.

# -----------------------

# 1.3 DATA CONSTRAINTS

# - One row represents one participant.
# - Participant identifiers must be unique.
# - Required participant fields must be populated.
# - Categorical values must follow their defined domains.
# - Enrollment dates must use a consistent date type.
# - The output must preserve its documented schema.



# ----------------------------------------------------------
# 02. TRIAL POPULATION MODELING
# ----------------------------------------------------------

# 2.1 POPULATION ATTRIBUTES

# The participant generator represents variation across:

# - Fictional investigation sites.
# - Fictional treatment groups.
# - Participation statuses.
# - Demographic attributes.
# - Enrollment dates.

# These attributes are generated using controlled
# synthetic sampling configurations.

# -----------------------

# 2.2 SAMPLING BEHAVIOR

# Population generation is designed to:

# - Support multiple participant characteristics.
# - Maintain consistent categorical definitions.
# - Produce structurally valid participant records.
# - Provide variation for downstream analytical testing.

# Internal distributions, sampling weights, and
# generation mechanisms are not publicly disclosed.


# -----------------------

# 2.3 REPRODUCIBILITY REQUIREMENTS

# Under an identical configuration and random seed:

# - Participant generation must be deterministic.
# - Repeated runs must produce equivalent datasets.
# - Column definitions and data types must remain stable.

# Different seeds may produce different synthetic
# populations while preserving the output contract.



# ----------------------------------------------------------
# 03. ADVERSE EVENT DATA GENERATION
# ----------------------------------------------------------

# 3.1 FUNCTION CONTRACT

# generate_adverse_event_data(df_patients, seed=42)

# Input:
#   df_patients : pandas.DataFrame
#       Participant dataset generated according to
#       the participant-level schema.

#   seed : int
#       Random seed controlling reproducibility.

# Output:
#   pandas.DataFrame
#       Zero or more adverse event records associated
#       with participants in the input dataset.

# Expected behavior:
#   - Use existing participant records as the source
#     of valid participant identifiers.
#   - Support multiple events for one participant.
#   - Generate unique event identifiers.
#   - Populate event terminology and classifications.
#   - Generate event onset and reporting dates.
#   - Represent event outcomes and resolution status.
#   - Return a consistently structured DataFrame.

# -----------------------

# 3.2 RELATIONAL MODEL

# Participant dataset:
#   Primary key: patient_id

# Adverse event dataset:
#   Primary key: ae_id
#   Foreign key: patient_id

# Relationship:
#   One participant -> zero or more adverse events.

# Referential invariant:
#   Every adverse event patient_id must reference
#   an existing participant in df_patients.

# Event counts must not be interpreted as the number
# of distinct participants experiencing events.

# -----------------------

# 3.3 OUTPUT SCHEMA

# ae_id
#   Unique identifier for a synthetic adverse event.

# patient_id
#   Reference to an existing synthetic participant.

# ae_start_date
#   Date representing adverse event onset.

# reported_date
#   Date representing adverse event reporting.

# ae_term
#   Simulated adverse event term.

# organ_system
#   Organ system associated with the event term.

# severity_grade
#   Simulated adverse event severity classification.

# is_serious
#   Boolean seriousness classification.

# drug_relationship
#   Simulated relationship to study treatment.

# ae_outcome
#   Simulated adverse event outcome.

# resolved
#   Nullable indicator of event resolution status.

# -----------------------

# 3.4 CLINICAL CLASSIFICATION CONSTRAINTS

# Adverse event terminology:
#   Event terms must belong to the supported
#   synthetic terminology domain.

# Organ system:
#   Organ system assignments must be consistent
#   with their associated event terms.

# Severity:
#   Severity classifications must use the
#   model's defined grading domain.

# Seriousness:
#   Seriousness is represented independently
#   from severity.

# Treatment relationship:
#   Relationship classifications must belong
#   to the model's defined categorical domain.

# Outcome:
#   Outcome values must follow the supported
#   synthetic outcome classifications.

# Resolution:
#   Resolution status must remain consistent
#   with the assigned outcome.

# Missing resolution information must be
# represented explicitly where applicable.

# These constraints assess the consistency of
# synthetic classifications, not the clinical
# accuracy of real-world safety assessments.

# -----------------------

# 3.5 DATA INTERPRETATION

# Each row represents an adverse event record,
# not a unique participant.

# Severity and seriousness are separate variables
# and must not be used interchangeably.

# Treatment relationship is a simulated
# classification, not evidence of causality.

# Event outcomes and resolution indicators
# represent synthetic record states.

# The generated data must not be interpreted
# as observed clinical safety evidence.

# -----------------------

# 3.6 TEMPORAL CONSTRAINTS

# Enrollment and event onset:
#   ae_start_date must not precede the
#   participant's enrollment_date.

# Follow-up:
#   ae_start_date must fall within the
#   configured follow-up observation window.

# Event onset and reporting:
#   reported_date must not precede ae_start_date.

# Reporting interval:
#   Reporting delays must satisfy the model's
#   internal temporal constraints.

# Reporting dates are distinct from onset dates.
# The synthetic reporting interval does not
# represent a regulatory reporting deadline.



# ----------------------------------------------------------
# 04. DATA VALIDATION
# ----------------------------------------------------------

# 4.1 STRUCTURAL INTEGRITY

# Validation requirements:

# - Expected output columns are present.
# - Column ordering remains consistent.
# - Data types match the defined schemas.
# - Required identifiers are not missing.
# - Nullable fields preserve valid missing values.
# - Generated outputs retain tabular consistency.

# -----------------------

# 4.2 REFERENTIAL INTEGRITY

# Validation requirements:

# - Participant identifiers are unique.
# - Adverse event identifiers are unique.
# - No adverse event references an unknown participant.
# - Multiple events per participant are supported.
# - Participant and event counts remain distinguishable.

# -----------------------

# 4.3 CLINICAL CONSISTENCY

# Validation requirements:

# - Event terms belong to the supported domain.
# - Organ system mappings are internally consistent.
# - Severity classifications are valid.
# - Seriousness classifications are valid.
# - Treatment relationship values are valid.
# - Event outcomes belong to the supported domain.
# - Resolution indicators are compatible with outcomes.



# ----------------------------------------------------------
# IMPLEMENTATION BOUNDARY
# ----------------------------------------------------------

# This public specification defines the intended interface.
# Sampling algorithms, distributions, and executable
# generation logic are maintained in the private codebase.

# The public module is not an executable implementation.
